309 results
Page 12 of 16
DFAN14A
nd1ybv1brxl3zkde5f
11 Apr 19
Additional proxy materials by non-management
5:17pm
8-K
EX-99.1
51s h3q2dlymmz
11 Apr 19
MiMedx Announces Board Approval of Long-Range Strategic Plan
4:40pm
8-K
EX-99.2
vlt0pjk03tr7gb
6 Dec 18
Mimedx Announces Organizational Realignment Program
6:10am
8-K
EX-99.1
xccfnfq9wcpdl 8wt
6 Dec 18
Mimedx Announces Organizational Realignment Program
6:10am
8-K
EX-99.1
aok14
7 Nov 18
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
t2bxzvr8caw3bo6h
7 Nov 18
Mimedx Receives Nasdaq Delisting Notification
8:24am
8-K
EX-99.1
phk3mxo zpdm
21 Sep 18
Mimedx Announces Nasdaq Listing Extension
12:00am
8-K
EX-99.1
8cpdn9
20 Sep 18
Mimedx Provides Update on Previously Announced Senior Executive Separations
5:17pm
8-K
EX-99.1
bz10u5lhl3c
26 Jul 18
Mimedx Announces Receipt of Nasdaq Letter
5:26pm
8-K/A
yx0xoyyu
11 Jul 18
Departure of Directors or Certain Officers
8:01am
8-K
EX-99.1
tlj0a1
2 Jul 18
Mimedx Announces Leadership Changes and Corporate Actions
8:03am
8-K
EX-99.1
hzo3 8slesestm6om4
7 Jun 18
Mimedx to Restate Certain Historical Financial Statements
7:02am
8-K
EX-99.1
aewbjvgnut 2w2m2
18 May 18
MiMedx Receives NASDAQ Notice of Late Form 10-Q Filing
4:31pm
8-K
EX-99.1
5856 5c7ix3vshoi07r
26 Apr 18
Mimedx Reports Unreviewed First Quarter Revenue Exceeds Upper End of Its Guidance
9:06am
8-K
EX-99.1
d9gu21i
17 Jul 17
MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range
12:00am
8-K
EX-99.1
bz02e0 z3
13 Apr 17
MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance
12:00am